// App-Quantinova.ai

: Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease

Researchers

Presenter

  • S. Matson

Principal Investigators

  • D. Dvorkin

  • A. Fischer

  • N. Achtar-Zadeh

  • P. J. Wolters

  • J. S. Lee

Medical Centers

  • Pulmonary and Critical Care, University of Colorado, Aurora, CO, United States.

  • University of Colorado School of Medicine, Aurora, CO, United States

  • UCSF, San Francisco, United States

  • Univ of California At San Francisco, San Francisco, CA, United States.

  • Univ of Colorado Denver, Aurora, CO, United States,

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Pulmonary/Respiratory Diseases

Disease

  • Idiopathic pulmonary fibrosis

  • Interstitial lung disease

  • Scleroderma

  • Pulmonary fibrosis

Biomarkers

  • C-X-C Motif Chemokine Ligand 13

  • Matrilysin

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A